168 related articles for article (PubMed ID: 15375711)
1. PIVKA-II-producing advanced gastric cancer.
Takano S; Honda I; Watanabe S; Soda H; Nagata M; Hoshino I; Takenouchi T; Miyazaki M
Int J Clin Oncol; 2004 Aug; 9(4):330-3. PubMed ID: 15375711
[TBL] [Abstract][Full Text] [Related]
2. Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Iso Y; Sawada T; Shimoda M; Rokkaku K; Ohkura Y; Kubota K
Hepatogastroenterology; 2005; 52(66):1930-2. PubMed ID: 16334809
[TBL] [Abstract][Full Text] [Related]
3. Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer.
Kudo M; Takamine Y; Nakamura K; Shirane H; Uchida H; Kasakura S; Kajiwara T; Ibuki Y; Hirasa M; Tomita S
Am J Gastroenterol; 1992 Dec; 87(12):1859-62. PubMed ID: 1280406
[TBL] [Abstract][Full Text] [Related]
4. [Demonstration of PIVKA-II and AFP production by gastric cancer by indirect immunoenzymatic staining of paraffin sections].
Nakamura K; Sakizono K; Oita T; Kudo M; Shirane H; Uchida H; Kasakura S
Rinsho Byori; 1991 Jun; 39(6):605-9. PubMed ID: 1715411
[TBL] [Abstract][Full Text] [Related]
5. Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation.
Hasegawa Y; Tomita K; Hashimoto K; Shigeoka Y; Watanabe M; Yamasaki A; Shimizu E
Anticancer Res; 2005; 25(6C):4569-71. PubMed ID: 16334143
[TBL] [Abstract][Full Text] [Related]
6. [A surgically resected case of AFP and PIVKA-II producing gastric cancer with hepatic metastasis].
Tomono A; Wakahara T; Kanemitsu K; Toyokawa A; Teramura K; Iwasaki T
Nihon Shokakibyo Gakkai Zasshi; 2013 May; 110(5):852-60. PubMed ID: 23648542
[TBL] [Abstract][Full Text] [Related]
7. [A case of AFP and PIVKA-II producing gastric carcinoma].
Tanaka H; Ishii S; Akutsu N; Ohashi H; Tokuno T; Suzuki T; Okuda H; Shinomura Y; Imai K
Nihon Shokakibyo Gakkai Zasshi; 2006 Apr; 103(4):426-31. PubMed ID: 16629462
[TBL] [Abstract][Full Text] [Related]
8. Des-gamma carboxy prothrombin (PIVKA-II)- and alpha-fetoprotein (AFP)-producing gastric cancer.
Takahashi Y; Endo H; Tange T; Kurabayashi R; Nomura S; Kaminishi M; Tange T
J Gastroenterol; 2005 Apr; 40(4):432-3. PubMed ID: 15870980
[No Abstract] [Full Text] [Related]
9. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma].
Fujiyama S; Morishita T; Shibata J; Sato T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
11. [Adrenal hepatoid carcinoma producing alpha-fetoprotein: a case report].
Yoshioka M; Ihara H; Shima H; Mori Y; Ikoma F; Ueno Y; Uematsu K
Hinyokika Kiyo; 1994 May; 40(5):411-4. PubMed ID: 7517622
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
13. [Gastric cancer with liver metastasis producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II); a case report].
Okuse C; Yotsuyanagi H; Takahashi Y; Hayashi T; Suzuki M; Iino S; Ogata S; Maeyama S; Uchikoshi T; Iwabuchi S
Nihon Shokakibyo Gakkai Zasshi; 2003 Jan; 100(1):28-34. PubMed ID: 12601925
[No Abstract] [Full Text] [Related]
14. A resected case of metachronous liver metastasis from lung cancer producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II).
Oshiro Y; Takada Y; Enomoto T; Fukao K; Ishikawa S; Iijima T
Hepatogastroenterology; 2004; 51(58):1144-7. PubMed ID: 15239263
[TBL] [Abstract][Full Text] [Related]
15. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Tanaka Y; Kashiwagi T; Tsutsumi H; Nagasawa M; Toyama T; Ozaki S; Naito M; Ishibashi K; Azuma M
Hepatogastroenterology; 1999; 46(28):2464-8. PubMed ID: 10522021
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Yano Y; Yamashita F; Kuwaki K; Fukumori K; Kato O; Yamamoto H; Ando E; Tanaka M; Sata M
Liver Int; 2006 Sep; 26(7):789-95. PubMed ID: 16911460
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.
Fujiyama S; Morishita T; Sagara K; Sato T; Motohara K; Matsuda I
Hepatogastroenterology; 1986 Oct; 33(5):201-5. PubMed ID: 2433199
[TBL] [Abstract][Full Text] [Related]
18. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Fujioka M; Nakashima Y; Nakashima O; Kojiro M
Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of PIVKA-II as a marker of hepatocellular carcinoma].
Arima K; Kodama T; Suga M; Sakamoto H; Ohe Y; Yachi A
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3049-52. PubMed ID: 2476968
[TBL] [Abstract][Full Text] [Related]
20. Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Nasu M; Soma T; Fukushima H; Kudo K; Matsubara O
Mod Pathol; 1997 Oct; 10(10):1054-8. PubMed ID: 9346187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
